Literature DB >> 10453390

How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?

S Jost1, C W Nolte, M Sturm, J Hausleiter, D Hausmann.   

Abstract

In patients with coronary artery disease including those after coronary bypass graft operation and heart transplantation intervention studies based on serial quantitative coronary angiography, in part combined with intravascular ultrasound, are of increasing relevance. Since vasomotor tone of epicardial coronary arteries is influenced by a variety of factors, angiographic follow-up studies require standardization of coronary tone by induction of maximal dilation. We reviewed the effects of the most potent coronary vasodilatory drug groups, calcium antagonists and nitrocompounds, on coronary diameters. Intravenous or intracoronary injections of verapamil, diltiazem, nifedipine, nicardipine, and nisoldipine can cause profound coronary dilation which has been shown to be maximal with verapamil and nisoldipine. Shortcomings of calcium antagonists include short or unknown duration of action after bolus administration, severe drop in blood pressure, and lack of commercial availability of solutions for injection of many substances. Isosorbide dinitrate induces profound coronary dilation; however, after sublingual administration marked blood pressure decrease can occur, and the duration of action and ideal dose of intracoronary isosorbide dinitrate has not been investigated yet. Injections of molsidomine and its active metabolite, SIN-1, cause longlasting, reproducible, maximal coronary dilation, although only after a waiting period of at least 10 minutes; unfortunately, SIN-1 is only commercially available in France. Nitroglycerin induces reproducible maximal coronary dilation and is easy to administer sublingually or as intracoronary bolus injection with rapid onset of action and no major side effects. The short duration of action may require repeated administrations. To date, repeated intracoronary bolus injections of 0.1 mg nitroglycerin every 10 minutes seem to be the optimal known regimen for standardization of coronary vasomotor tone in serial angiographic studies. Further investigations in this field with old and new vasodilatory drugs are recommendable.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10453390     DOI: 10.1023/a:1006076409185

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  101 in total

1.  Vasodilatory effects of nisoldipine on coronary arteries--correlation with plasma levels.

Authors:  S Jost; W Rafflenbeul; B Mogwitz; D Gulba; H Hecker; P R Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

2.  Long-acting coronary vasodilatory action of the molsidomine metabolite Sin 1: a quantitative angiographic study.

Authors:  P W Serruys; J W Deckers; H E Luijten; J H Reiber; J G Tijssen; D Chadha; P G Hugenholtz
Journal:  Eur Heart J       Date:  1987-03       Impact factor: 29.983

3.  Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure.

Authors:  R L Lange; M S Reid; D D Tresch; M H Keelan; V M Bernhard; G Coolidge
Journal:  Circulation       Date:  1972-10       Impact factor: 29.690

4.  Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.

Authors:  M H Frick; M Syvänne; M S Nieminen; H Kauma; S Majahalme; V Virtanen; Y A Kesäniemi; A Pasternack; M R Taskinen
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

5.  Preserved vasodilatory response to nitroglycerin in saphenous vein bypass grafts.

Authors:  H Berglund; H Luo; T Nishioka; N L Eigler; C J Kim; S W Tabak; R J Siegel
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

6.  [Dynamics of critical stenosis in patients with unstable angina pectoris].

Authors:  K R Karsch; P Niemczyk; W Voelker; L Seipel
Journal:  Z Kardiol       Date:  1984-09

7.  [Dilatation of epicardial coronary vessels by intravenous diltiazem in patients with coronary heart disease].

Authors:  T Bonzel; H Wollschläger; H Löllgen; T Münzel; A Zeiher; R Tarnowska; B Wehrle; H Just
Journal:  Z Kardiol       Date:  1985-04

8.  Vasomotor response to ergometrine and nitrates of saphenous vein grafts, internal mammary artery grafts, and grafted coronary arteries late after bypass surgery.

Authors:  C Hanet; A Robert; W Wijns
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

9.  Coronary reactivity to nitroglycerin: intravascular ultrasound evidence for the importance of plaque distribution.

Authors:  M Yamagishi; S E Nissen; D C Booth; J C Gurley; J Koyama; S Kawano; A N DeMaria
Journal:  J Am Coll Cardiol       Date:  1995-01       Impact factor: 24.094

10.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

Authors:  D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

View more
  2 in total

1.  Using multidetector computed tomography in a swine model to assess the effects of sublingual nitroglycerin and intravenous adenosine on epicardial coronary arteries.

Authors:  Wesley A Clarkson; Carlos Santiago Restrepo; Terry D Bauch; Bernard J Rubal
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

2.  Noninvasive test of nitrate-induced coronary vasomotion by 1.5-T whole-heart 3D magnetic resonance angiography using a T2-prepared SSFP sequence.

Authors:  Hang Jin; Meng-Su Zeng; Hong Yun; Mei-Ying Ge; Jian-Ying Ma; Shan Yang
Journal:  Int J Cardiovasc Imaging       Date:  2011-12-21       Impact factor: 2.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.